Related Experiment Video
Updated: Jan 1, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer
Danuta Sastre1,2, João Baiochi2, Ildercilio Mota de Souza Lima2
1Laboratory of Human and Medical Genetics, Federal University of Pará, Rua Augusto Corrêa, 01. Guamá., Belém, Pará, CEP 66075-110, Brazil.
Background:
Colorectal cancer (CRC) is still a leading cause of death worldwide. Recent studies have pointed to an important role of microRNAs in carcinogenesis. Several microRNAs are described as aberrantly expressed in CRC tissues and in the serum of patients. However, functional outcomes of microRNA aberrant expression still need to be explored at the cellular level. Here, we aimed to investigate the effects of microRNAs aberrantly expressed in CRC samples in the proliferation and cell death of a CRC cell line.
Methods:
We transfected 31 microRNA mimics into HCT116 cells. Total number of live propidium iodide negative (PI-) and dead (PI+) cells were measured 4 days post-transfection by using a high content screening (HCS) approach. HCS was further used to evaluate apoptosis (via Annexin V and PI staining), and to discern between intrinsic and extrinsic apoptotic pathways, by detecting cleaved Caspase 9 and 8, respectively. To reveal mRNA targets and potentially involved mechanisms, we performed microarray gene expression and functional pathway enrichment analysis. Quantitative PCR and western blot were used to validate potential mRNA targets.
Results:
Twenty microRNAs altered the proliferation of HCT116 cells in comparison to control. miR-22-3p, miR-24-3p, and miR-101-3p significantly repressed cell proliferation and induced cell death. Interestingly, all anti-proliferative microRNAs in our study had been previously described as poorly expressed in the CRC samples. Predicted miR-101-3p targets that were also downregulated by in our microarray were enriched for genes associated with Wnt and cancer pathways, including MCL-1, a member of the BCL-2 family, involved in apoptosis. Interestingly, miR-101-3p preferentially downregulated the long anti-apoptotic MCL-1 L isoform, and reduced cell survival specifically by activating the intrinsic apoptosis pathway. Moreover, miR-101-3p also downregulated IL6ST, STAT3A/B, and MYC mRNA levels, genes associated with stemness properties of CRC cells.
Conclusions:
microRNAs upregulated in CRC tend to induce proliferation in vitro, whereas microRNAs poorly expressed in CRC halt proliferation and induce cell death. We provide novel evidence linking preferential inhibition of the anti-apoptotic MCL-1 L isoform by miR-101-3p and consequent activation of the intrinsic apoptotic pathway as potential mechanisms for its antitumoral activity, likely due to the inhibition of the IL-6/JAK/STAT signaling pathway.
Insights
MicroRNAs poorly expressed in colorectal cancer (CRC) can halt proliferation and induce cell death. MiR-101-3p preferentially inhibits anti-apoptotic MCL-1, activating intrinsic apoptosis and offering potential CRC therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) remains a significant global health burden.
- MicroRNAs play a crucial role in cancer development (carcinogenesis).
- Aberrant microRNA expression is observed in CRC tissues and patient serum, necessitating functional exploration.
Purpose of the Study:
- To investigate the cellular effects of microRNAs aberrantly expressed in CRC.
- To determine the impact of specific microRNAs on colorectal cancer cell proliferation and death.
Main Methods:
- Transfection of 31 microRNA mimics into HCT116 colorectal cancer cells.
- High-content screening (HCS) to quantify cell viability and apoptosis.
- Analysis of apoptotic pathways (intrinsic and extrinsic) and gene expression (microarray, qPCR, Western blot).
Main Results:
- Twenty microRNAs modulated HCT116 cell proliferation; miR-22-3p, miR-24-3p, and miR-101-3p significantly repressed proliferation and induced cell death.
- These anti-proliferative microRNAs were previously found to be downregulated in CRC samples.
- miR-101-3p preferentially downregulated the anti-apoptotic MCL-1 long isoform, activating intrinsic apoptosis and reducing stemness-associated genes (IL6ST, STAT3A/B, MYC).
Conclusions:
- MicroRNAs upregulated in CRC tend to promote proliferation, while those downregulated inhibit proliferation and induce cell death.
- miR-101-3p's anti-tumoral activity is linked to preferential inhibition of MCL-1 long isoform, activating intrinsic apoptosis.
- This mechanism likely involves the inhibition of the IL-6/JAK/STAT signaling pathway.
More Related Videos
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Related Concept Videos
MicroRNAs
MicroRNAs